Carl Chiang - Concepedia

Author

Carl Chiang

Deerfield (United States)

Also Known As

, C. Chiang, C.-F. Chiang, Carl Chiang

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Deerfield (United States)Takeda (United States)Duke Medical Center Research Triangle Park Foundation Duke University

About

Carl Chiang is an author at Deerfield (United States) specializing in neurodegenerative diseases, alzheimer's disease, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	122
2	Neurology	2	2	122
3	Neuroscience	2	2	122
4	Social Sciences	1	1	108
5	Psychiatry	1	1	14

Carl Chiang

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Top-down processing mediated by interareal synchronization Astrid von Stein, Carl Chiang, Peter König Proceedings of the National Academy of Sciences	2000	733
Rosiglitazone Does Not Improve Cognition or Global Function when Used as Adjunctive Therapy to AChE Inhibitors in Mild-to-Moderate Alzheimers Disease: Two Phase 3 Studies Conn Harrington, Sharon Sawchak, Carl Chiang, Current Alzheimer Research	2011	192
Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial Daniel K. Burns, Robert Alexander, Kathleen A. Welsh‐Bohmer, The Lancet Neurology Neurodegenerative DiseasesNeuropsychologyAlzheimer's DiseaseDementiaVascular Dementia	2021	108
Bi-directional interactions between visual areas in the awake behaving cat Corrado Bernasconi, Astrid von Stein, Carl Chiang, Neuroreport	2000	48
The TOMMORROW study: Design of an Alzheimer's disease delay‐of‐onset clinical trial Daniel K. Burns, Carl Chiang, Kathleen A. Welsh‐Bohmer, Alzheimer s & Dementia Translational Research & Clinical Interventions	2019	41
P4‐269: A pharmacogenetic‐supported clinical trial to delay onset of mild cognitive impairment (MCI) due to Alzheimer's disease (AD) Allen D. Roses, Kathleen A. Welsh‐Bohmer, Daniel K. Burns, Alzheimer s & Dementia AgingApoe GeneNeurochemical BiomarkersAd ContinuumPharmacogenetic‐supported Clinical Trial	2012	14
TOMMORROW neuropsychological battery: German language validation and normative study Heather Romero, Andreas U. Monsch, Kathleen M. Hayden, Alzheimer s & Dementia Translational Research & Clinical Interventions	2018	11

Page 1